IBDEI0QH ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11823,1,3,0)
 ;;=3^Malig Neop of Lower-Outer Quadrant of Left Breast
 ;;^UTILITY(U,$J,358.3,11823,1,4,0)
 ;;=4^C50.522
 ;;^UTILITY(U,$J,358.3,11823,2)
 ;;=^5133338
 ;;^UTILITY(U,$J,358.3,11824,0)
 ;;=C50.621^^80^759^3
 ;;^UTILITY(U,$J,358.3,11824,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11824,1,3,0)
 ;;=3^Malig Neop of Axillary Tail of Right Breast
 ;;^UTILITY(U,$J,358.3,11824,1,4,0)
 ;;=4^C50.621
 ;;^UTILITY(U,$J,358.3,11824,2)
 ;;=^5001186
 ;;^UTILITY(U,$J,358.3,11825,0)
 ;;=C50.622^^80^759^2
 ;;^UTILITY(U,$J,358.3,11825,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11825,1,3,0)
 ;;=3^Malig Neop of Axillary Tail of Left Breast
 ;;^UTILITY(U,$J,358.3,11825,1,4,0)
 ;;=4^C50.622
 ;;^UTILITY(U,$J,358.3,11825,2)
 ;;=^5001187
 ;;^UTILITY(U,$J,358.3,11826,0)
 ;;=C50.821^^80^759^14
 ;;^UTILITY(U,$J,358.3,11826,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11826,1,3,0)
 ;;=3^Malig Neop of Overlapping Sites of Right Breast
 ;;^UTILITY(U,$J,358.3,11826,1,4,0)
 ;;=4^C50.821
 ;;^UTILITY(U,$J,358.3,11826,2)
 ;;=^5001192
 ;;^UTILITY(U,$J,358.3,11827,0)
 ;;=C50.822^^80^759^13
 ;;^UTILITY(U,$J,358.3,11827,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11827,1,3,0)
 ;;=3^Malig Neop of Overlapping Sites of Left Breast
 ;;^UTILITY(U,$J,358.3,11827,1,4,0)
 ;;=4^C50.822
 ;;^UTILITY(U,$J,358.3,11827,2)
 ;;=^5001193
 ;;^UTILITY(U,$J,358.3,11828,0)
 ;;=C50.921^^80^759^15
 ;;^UTILITY(U,$J,358.3,11828,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11828,1,3,0)
 ;;=3^Malig Neop of Right Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,11828,1,4,0)
 ;;=4^C50.921
 ;;^UTILITY(U,$J,358.3,11828,2)
 ;;=^5001198
 ;;^UTILITY(U,$J,358.3,11829,0)
 ;;=C50.922^^80^759^6
 ;;^UTILITY(U,$J,358.3,11829,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11829,1,3,0)
 ;;=3^Malig Neop of Left Breast,Unspec Site
 ;;^UTILITY(U,$J,358.3,11829,1,4,0)
 ;;=4^C50.922
 ;;^UTILITY(U,$J,358.3,11829,2)
 ;;=^5133340
 ;;^UTILITY(U,$J,358.3,11830,0)
 ;;=N62.^^80^759^1
 ;;^UTILITY(U,$J,358.3,11830,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11830,1,3,0)
 ;;=3^Hypertrophy of Breast
 ;;^UTILITY(U,$J,358.3,11830,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,11830,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,11831,0)
 ;;=I25.10^^80^760^8
 ;;^UTILITY(U,$J,358.3,11831,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11831,1,3,0)
 ;;=3^Athscl Hrt Disease of Native Coronary Artery w/o Ang Pctrs
 ;;^UTILITY(U,$J,358.3,11831,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,11831,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,11832,0)
 ;;=I50.9^^80^760^22
 ;;^UTILITY(U,$J,358.3,11832,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11832,1,3,0)
 ;;=3^Heart Failure,Unspec
 ;;^UTILITY(U,$J,358.3,11832,1,4,0)
 ;;=4^I50.9
 ;;^UTILITY(U,$J,358.3,11832,2)
 ;;=^5007251
 ;;^UTILITY(U,$J,358.3,11833,0)
 ;;=I50.43^^80^760^5
 ;;^UTILITY(U,$J,358.3,11833,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11833,1,3,0)
 ;;=3^Acute on Chronic Combined Systolic/Diastolic Hrt Failure
 ;;^UTILITY(U,$J,358.3,11833,1,4,0)
 ;;=4^I50.43
 ;;^UTILITY(U,$J,358.3,11833,2)
 ;;=^5007250
 ;;^UTILITY(U,$J,358.3,11834,0)
 ;;=I50.42^^80^760^12
 ;;^UTILITY(U,$J,358.3,11834,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11834,1,3,0)
 ;;=3^Chronic Combined Systolic/Diastolic Hrt Failure
 ;;^UTILITY(U,$J,358.3,11834,1,4,0)
 ;;=4^I50.42
 ;;^UTILITY(U,$J,358.3,11834,2)
 ;;=^5007249
 ;;^UTILITY(U,$J,358.3,11835,0)
 ;;=I50.40^^80^760^15
 ;;^UTILITY(U,$J,358.3,11835,1,0)
 ;;=^358.31IA^4^2
